A Randomised Prospective Study Analysing the Effects of Lowering Serum Uric Acid in Chronic Kidney Disease (CKD) Progression and Cardiovascular Outcomes

Journal Title: Open Access Journal of Urology & Nephrology - Year 2019, Vol 4, Issue 1

Abstract

Uric acid is an independent risk factor for the development and progression of kidney disease. In last two decades number of observational studies has examined the potential link between management of hyperuricemia with CKD progression, having conflicted results. Hence, this prospective, randomised controlled study was conducted among stage 3-5 CKD patients in patients to evaluate the effect of lowering uric acid levels in reduction of hypertension, and kidney disease progression and cardiovascular risk. Patients were randomized into two groups, one group (n=100) receiving allopurinol with a dose of 100-300 mg/day plus standard treatment and other group (n=50) receiving only standard treatment. Patients were followed at 3, 6 and 12 months of treatment. After 12 months of allopurinol treatment, serum uric acid levels were significantly (p<0.0001) lowered (8.095 ± 0.877 mg/dL to 6.977 ± 0.569 mg/dL) in patients receiving allopurinol, whereas, the uric acid levels were significantly (p<0.0001) increased in control group (7.910 ± 0.701 mg/dL to 8.196 ± .741 mg/dL). A decrease in estimated glomerular filtration rate (eGFR) was observed at the end of 12 months in both the groups, but the decrease in eGFR was significantly more in the control group as compared to the allopurinol group (P<0.0001). There was no significant effect of allopurinol on cardiovascular outcomes. This study evaluated that lowering of serum uric acid was effective in slowing the renal disease progression and cardiovascular risk in patients with CKD as compared to the controls. However, no significant beneficial effect of allopurinol treatment was observed on hypertension and cardiovascular outcomes in these patients.

Authors and Affiliations

Lalit Pursnani

Keywords

Related Articles

Uretero-Arterial Fistula: A Modern Case of an Orphan Disease

Uretero-arterial fistula (UAF) is an uncommon source of hematuria, but as a harbinger of mortality, diagnosis can potentially be lifesaving. While rare, there is a general consensus that the incidence is rising. The cond...

Diabetic Kidney Disease: A New Concept for an Old Problem

Diabetes Mellitus (DM) is a growing worldwide epidemic. It was estimated that more than 366 million people would be affected. DM has spread its presence over the world due to lifestyle changes, increasing obesity and eth...

Interventional Radiology Techniques in the Genitourinary Tract

The increasing use of interventional radiology techniques for diagnosis and treatment in different fields of medicine has shown its great benefits since it involves techniques that avoid carrying out extensive procedures...

Non-Synaptic Mechanisms of Urinary Bubble Management

Scientific works of recent years have shown that neurogenic and non-neurogenic hyperactivity of the bladder is largely a consequence of detrusor ischemia, which is accompanied by structural and functional rearrangement o...

Decrease in Quality of Life and Functional Assessment in Elder Patients with End-Stage Renal Disease after Two Years of Hemodialysis Therapy

Introduction: Hemodialysis improves survival rates of Chronic Kidney Disease (CKD) patients but not Quality of Life (QoL) which decreases in a more aggressive way in the elderly population. We describe the reduction and...

Download PDF file
  • EP ID EP515999
  • DOI -
  • Views 41
  • Downloads 0

How To Cite

Lalit Pursnani (2019). A Randomised Prospective Study Analysing the Effects of Lowering Serum Uric Acid in Chronic Kidney Disease (CKD) Progression and Cardiovascular Outcomes. Open Access Journal of Urology & Nephrology, 4(1), 1-8. https://europub.co.uk/articles/-A-515999